Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 238
Filter
2.
Indian J Pathol Microbiol ; 64(1): 165-167, 2021.
Article in English | MEDLINE | ID: mdl-33433432

ABSTRACT

Strongyloides stercoralis is an intestinal nematode that infects humans, percutaneously and has a complex life cycle. We report a case of a thirty year old male presenting with chief complaints of profuse watery diarrhoea, abdominal fullness, loss of appetite, creepy abdominal pain and low-grade fever for the last one month. He was on corticosteroids for systemic sclerosis. Endoscopy showed thickened and oedematous duodenal folds with pinpoint areas of bleeding and multiple ulcerations on the duodenal mucosa. Histopathologial examination of duodenal biopsy revealed infestation by Strongyloides stercoralis in the duodenum, the duodenal mucosal glands were occupied by various parts of parasite. The patient was successfully treated and had uneventful recovery.


Subject(s)
Histological Techniques , Strongyloides stercoralis/pathogenicity , Strongyloidiasis/diagnosis , Strongyloidiasis/pathology , Abdominal Pain/parasitology , Adult , Animals , Anthelmintics/therapeutic use , Biopsy , Duodenum/pathology , Endoscopy , Humans , Intestinal Mucosa/pathology , Male , Strongyloides stercoralis/isolation & purification , Strongyloidiasis/drug therapy
4.
Biomedica ; 40(4): 599-603, 2020 12 02.
Article in English, Spanish | MEDLINE | ID: mdl-33275338

ABSTRACT

Myiasis is a pathology caused by the infestation of fly larvae species which affects vertebrates' tissues or organs including humans. It can be classified entomologically or according to tissue tropism. Intestinal myiasis is rare and difficult to diagnose given its non-specific symptoms; the only way to confirm a case is by identifying the expelled larvae. This is the first case of intestinal myiasis reported in the department of Nariño (Colombia) in a 6-year-old child from a low-income family in the urban area of the municipality of Policarpa where there is no adequate treatment and no disposition of wastewater and basic sanitation conditions are insufficient. The clinical case was related to chronic diarrhea, abdominal pain, and anal pruritus with the subsequent expulsion of a larva identified by its morphological characteristics as Eristalis tenax fly larva.


La miasis se produce por la infestación con larvas de especies de moscas que afectan los tejidos u órganos de los vertebrados, incluido el ser humano. Puede clasificarse por caracterización entomológica o según el tropismo de las larvas en los tejidos. La miasis intestinal es poco frecuente y de difícil diagnóstico dada su sintomatología inespecífica, p or lo que la única forma de confirmar el caso es mediante la identificación de las larvas expulsadas.Se presenta el primer caso reportado en el departamento de Nariño (Colombia) de miasis intestinal en un niño de seis años residente en la zona urbana del municipio de Policarpa, proveniente de una familia de nivel socioeconómico bajo, sin acceso a un adecuado tratamiento y sin disposición de aguas residuales y con insuficientes condiciones de saneamiento básico. El caso clínico se asoció con diarrea crónica, dolor abdominal y prurito anal, con la posterior expulsión de una larva cuyas características morfológicas correspondían a las de la mosca Eristalis tenax.


Subject(s)
Diptera , Myiasis/parasitology , Abdominal Pain/parasitology , Animals , Child , Diarrhea/parasitology , Feces/parasitology , Humans , Larva/anatomy & histology , Male , Poverty Areas , Wastewater
6.
J Infect Dev Ctries ; 14(9): 1071-1073, 2020 09 30.
Article in English | MEDLINE | ID: mdl-33031098

ABSTRACT

Porocephalosis is the name given to human infection by Armillifer, which is rare, especially in European and North American populations. Among the few cases reported to date, most of them were described in the African community. Humans can become infected, for example, consuming undercooked meat from infected snakes. Herein we report the case of a 31-year-old male, originally from the Democratic Republic of the Congo, who was living in France for many years and presented with lower back pain and mild abdominal pain. Imaging showed multiple comma-shaped calcifications disseminated in the liver and the peritoneal cavity, without any additional feature. The patient reported regular consumption of snake meat during his travels in Africa, and thus the diagnosis of porocephalosis could be made. Doctors treating patients from endemic areas or traveling in endemic areas, particularly in Africa, should become familiar with this infection and consider it in the case of multiple calcifications on imaging. More cases of porocephalosis are likely to be seen in the future because of the increase in international travel.


Subject(s)
Parasitic Diseases/diagnostic imaging , Pentastomida , Abdominal Pain/parasitology , Adult , Animals , Democratic Republic of the Congo , Humans , Liver/parasitology , Male , Radiologists , Snakes/parasitology , Tomography, X-Ray Computed
7.
BMC Infect Dis ; 20(1): 257, 2020 Mar 30.
Article in English | MEDLINE | ID: mdl-32228484

ABSTRACT

BACKGROUND: Cryptosporidium sp. are common intracellular parasites responsible of severe diarrhea in T-cell-immunocompromised patients. We report the first case of a woman who contracted cryptosporidiosis after treatment with fingolimod, a drug labeled for multiple sclerosis and responsible for marked lymphopenia. CASE PRESENTATION: A 60-year-old woman was admitted for abdominal pain diarrhea and fever. The patient suffered from multiple sclerosis and had been treated with fingolimod from august 2017 to september 2018 time of occurrence of the first digestive symptoms. Stool culture was negative but parasitological examination was positive for Cryptosporidium sp. Blood biological examination profound lymphopenia of 240/mm3 [17 CD4/mm3 (7%) and 32 CD8/mm3 (14%)]. Fingolimod was stopped, and the patient was put on nitazoxanide 500 mg bid for 7 days. The diarrhea resolved and no relapse was observed. Six other cases were found in the Pharmacovigilance database. CONCLUSION: Physicians should be aware of this association and screen for Cryptosporidium in cases of diarrhea in patients treated with fingolimod. Patients should be aware of this risk and advise to take appropriate measures to avoid such contamination.


Subject(s)
Cryptosporidiosis/drug therapy , Diarrhea/parasitology , Fingolimod Hydrochloride/adverse effects , Abdominal Pain/parasitology , Animals , Antiparasitic Agents/therapeutic use , Cryptosporidiosis/parasitology , Diarrhea/etiology , Feces/parasitology , Female , Fever/parasitology , Fingolimod Hydrochloride/therapeutic use , Humans , Immunocompromised Host , Middle Aged , Multiple Sclerosis/drug therapy , Nitro Compounds , Pharmacovigilance , Thiazoles/therapeutic use
8.
Expert Rev Gastroenterol Hepatol ; 14(4): 231-242, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32155096

ABSTRACT

Introduction: The presence of D. fragilis in feces is characterized by an asymptomatic carrier ship to a spectrum of gastrointestinal symptoms. However, a causal relationship remains to be elucidated. In this systematic review, we aimed to evaluate the relationship between the eradication of D. fragilis and symptoms to establish the strength of evidence that D. fragilis in symptomatic children warrants antibiotic treatment.Areas covered: This systematic review covers a challenge in daily clinical practice. Is it necessary to test for D. fragilis in children with gastrointestinal symptoms and does a positive fecal PCR test warrant treatment?Expert opinion: Testing for D. fragilis seems justified in a selection of children with persistent unexplained chronic abdominal pain and diarrhea. Treatment of D. fragilis should be withhold until other causes like celiac disease have been excluded. Both microscopic and Real Time-PCR methods (or a combination of the two) can be used for diagnosis. Paromomycin or clioquinol are antibiotics of choice based on their small spectrum of activity, fewer side effects, and better eradication rates than metronidazole. Future randomized studies, with strict inclusion criteria, appropriate diagnostic testing, and doses of antibiotics based on bodyweight are warranted.


Subject(s)
Dientamoebiasis/diagnosis , Dientamoebiasis/drug therapy , Abdominal Pain/drug therapy , Abdominal Pain/etiology , Abdominal Pain/parasitology , Child , Diagnosis, Differential , Diarrhea/drug therapy , Diarrhea/etiology , Diarrhea/parasitology , Dientamoeba/isolation & purification , Dientamoebiasis/complications , Dientamoebiasis/parasitology , Feces/parasitology , Humans , Real-Time Polymerase Chain Reaction , Treatment Outcome
9.
Eur J Pediatr ; 179(6): 979-984, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32020333

ABSTRACT

Blastocystis is a parasite with a worldwide distribution and a varying prevalence in different countries. The pleomorphic nature of the protozoon and the lack of understanding a possible pathogenesis have led to confusion regarding its clinical significance. The aim of the study was to shed light on clinical characteristics of pediatric patients in Swiss children with a positive stool sample for Blastocystis, in order to provide recommendations for a practical approach for the clinician to know whom, when, and how to test. This is a retrospective study of pediatric patients, whose stool has been tested positive for Blastocystis in the last 10 years in northern Switzerland. A total of 4047 stool samples, belonging to 1887 different patients, were analyzed; 240 stool samples (of 160 patients) were tested positive for Blastocystis. On average, 2.2 (CI 1.98-2.35) stool samples per patient were analyzed, of which 1.48 (CI 1.36-1.61) were positive for Blastocystis. In 63% abdominal pain was the leading symptom, while in 17.5% it was an accidental finding without symptoms. There was a high significance in correlation of abdominal pain and chronicity (p < 0.0001) but none in diarrhea (p = 0.082) nor nausea/vomiting or other symptoms and chronicity. Followed by Entamoeba coli (8%), 26.3% of the patients with Blastocystis had a co-infection with another parasite, mostly Endolimax nana (13%).Conclusion: Carriage of Blastocystis is common; therefore, only children/teenagers at risk for a symptomatic Blastocystis infection should be tested. There is a good correlation between Blastocystis and chronic abdominal pain. Children with abdominal symptoms persisting over 4 weeks should have two different stool samples analyzed. No screening after travels/immigration is recommended.What is Known:• Blastocystis has a worldwide distribution.• The clinical significance is unclear.What is New:• Based on retrospective data, we recommend to only test children/teenagers with chronic abdominal pain for Blastocystis.• Two different stool samples should be examined by microscopy; serological investigations are not warranted.


Subject(s)
Blastocystis Infections/diagnosis , Blastocystis Infections/epidemiology , Abdominal Pain/parasitology , Adolescent , Blastocystis/isolation & purification , Blastocystis Infections/complications , Blastocystis Infections/therapy , Child , Child, Preschool , Chronic Pain/parasitology , Coinfection/epidemiology , Diarrhea/parasitology , Feces/parasitology , Female , Humans , Infant , Infant, Newborn , Male , Prevalence , Retrospective Studies , Switzerland/epidemiology
10.
Article in Portuguese | LILACS | ID: biblio-1282619

ABSTRACT

Introdução: As enteroparasitoses são foco de investigações científicas no mundo todo. Urbanorumspp. foi reconhecido como parasita em 1994 no Peru, expandindo-se pela América do Sul. Relatado pela primeira vez no Brasil em 2018, Maranhão. Este relato apresenta o segundo caso no estado do Paraná. Relato de caso: Paciente masculino, 56 anos, 75kg, diabético, habitante de São José dos Pinhais, área urbana. Procura atenção primária por dor ao evacuar, tenesmo e cólica abdominal. Nega diarréia, febre, sangue nas fezes e viagem recente. Exame físico abdominal, hemograma e parcial de urina sem alterações. Parasitológico de fezes: Urbanorum spp. Prescrito Nitazoxanida 500mg 12/12h por 3 dias. Paciente retorna com melhora da sintomatologia e parasitológico de controle negativo. Conclusão: Atualmente a escassez de estudos primários prospectivos dificultam o delineamento clínico-epidemiológico e tratamento da parasitose. A disseminação do parasita entre extremos do país em curto intervalo de tempo, aliada à carência de saneamento básico criam um alerta para seu grande potencial epidêmico. Por isso, as políticas de saúde pública devem priorizar ações informativas e preventivas a fim de evitar surtos e complicações. A atenção primária à saúde é fundamental nesse contexto, justamente pela longitudinalidade e abrangência do cuidado.


Background: Enteroparasitosis are the focus of scientific research worldwide. Urbanorum spp. was recognized as a parasite in Peru in 1994, expanding throughout South America. Reported for the first time in Brazil, state of Maranhão, in 2018. This report presents the second case in the state of Paraná. Case report: Male patient, 56 years old, 75kg, diabetic, inhabitant of São José dos Pinhais, urban area, seeks primary care for pain on bowel movement, tenesmus and abdominal cramps. Denies diarrhea, fever, bloody stools, recent trip. Abdominal examination, blood count and partial urine without changes. Stool parasitology: urbanorum spp. Prescribed Nitazoxanide 500mg 12/12h for 3 days. Patient returns with improvement of symptomatology and parasitological negative control. Conclusion:Currently, the scarcity of prospective studies and meta-analyzes make clinical-epidemiological design and treatment of parasitosis difficult. The spread of the parasite between extremes of the country in a short period of time, coupled with the lack of basic sanitation create a warning for its great epidemic potential. Therefore, public health policies should prioritize informative and preventive actions in order to avoid outbreaks and complications. Primary health care is fundamental in this context, precisely because of the longitudinally and comprehensiveness of care.


Introducción: Las enteroparasitosis el punto de enfoque de investigaciones científicas en todo el mundo. Urbanorum spp fue reconocido cómo parásito en 1994 en el Peru, expandiéndose en América do Sul. Relatado por primera vez en Brasil, Maranhão, 2018. Este informe se encuentra en segundo lugar en el estado de Paraná. Relato del caso: Paciente masculino, 56 años, 75 kg, diabético, habitante de São José dos Pinhais, área urbana. Búsqueda atención primaria por dolor al defecar, tenesmo, y dolor abdominal. Nega diarrea, fiebre, sangre en heces o viaje reciente. Examen físico abdominal, hemograma e tests de orina sin modificaciones. Análisis parasitología: urbanorum spp. Prescripto Nitazoxanide 500mg 12/12h durante 3 días. Paciente volvió con alivio sintomático e materia fecal negativo. Conclusión: En la actualidad la escasez de estudios prospectivos y metanálisis dificultan la delineación clínico-epidemiológica y el tratamiento de la parasitosis. La diseminación del parásito entre los extremos del país en un corto período de tiempo, junto con la falta de saneamiento básico, crea una alerta por su gran potencial epidémico. Por lo tanto, las políticas de salud pública deben priorizar las acciones informativas y preventivas para evitar brotes y complicaciones. La atención primaria de salud es fundamental en este contexto, precisamente por la longitudinalidad y la amplitud de la atención.


Subject(s)
Humans , Male , Middle Aged , Protozoan Infections/diagnosis , Abdominal Pain/parasitology , Intestinal Diseases, Parasitic/diagnosis , Protozoan Infections/drug therapy , Intestinal Diseases, Parasitic/drug therapy , Antiprotozoal Agents/therapeutic use
11.
Infect Disord Drug Targets ; 20(3): 396-400, 2020.
Article in English | MEDLINE | ID: mdl-30868967

ABSTRACT

Giardia lamblia has proved to be the most common intestinal protozoan parasite in humans that causes giardiasis. Given the high mutations in the genome of this parasite, the present study was conducted to determine the prevalence of Giardia lamblia subtypes and their relationship with clinical symptoms in patients who appear to have giardiasis. In 69 stool specimens with an appropriate number of giardia cysts, the DNA was first purified, and the genotype was then determined based on the glutamate dehydrogenase (gdh) gene sequence using PCR-RFLP. Data were collected on the clinical symptoms of the patients through a questionnaire, and their relationship with molecular results was studied. Four samples (5.8%) were found to be of subtype AI, 51 (73.9%) of subtype AII and 14 (20.3 %) of subtype BIII. No BIV subtype was found in the present study. A correlation was observed between Giardia lamblia genotypes (AI, AII and BIII) and abdominal pain. All of the people (100%) who had the AI genotype (i.e. the zoonosis subtype) had been losing weight. There was a significant correlation between weight loss and the AI subtype. All of the people (100%) infected with the BIII genotype experienced diarrhea, and this genotype was found to be associated with diarrhea. The present study found abdominal pain to be the most common symptom of giardiasis in Ilam province. Moreover, humans were found to be the main reservoir for giardia lamblia, although zoonosis subtypes such as AI and BIII still exist in the region and pose a risk for a giardiasis epidemic.


Subject(s)
Giardia lamblia/classification , Giardiasis/epidemiology , Intestinal Diseases, Parasitic/physiopathology , Abdominal Pain/parasitology , Adolescent , Adult , Aged , Animals , Child , Child, Preschool , Diarrhea/parasitology , Feces/parasitology , Female , Genotype , Giardia lamblia/pathogenicity , Giardiasis/parasitology , Humans , Infant , Infant, Newborn , Iran/epidemiology , Male , Middle Aged , Prevalence , Protozoan Proteins/genetics , Surveys and Questionnaires , Young Adult , Zoonoses/parasitology
15.
BMJ Case Rep ; 12(12)2019 Dec 09.
Article in English | MEDLINE | ID: mdl-31822534

ABSTRACT

An 81-year-old Jamaican man who has been resident in the UK for many years presented with one week history of generalised abdominal pain, postprandial vomiting, anorexia, weight loss and abdominal distension. He was managed conservatively for acute small bowel obstruction. Investigations revealed a duodenal stricture. Live Strongyloides stercoralis larvae were observed in stool samples and duodenal biopsy confirmed the presence of the parasite at multiple life cycle stages within the lamina propria. He was diagnosed with Strongyloides hyperinfection with underlying human T-cell lymphotropic virus type 1 and treated with a prolonged course of ivermectin with ongoing monitoring for relapse. This case demonstrates a rare but potentially fatal cause of small bowel obstruction.


Subject(s)
Antiparasitic Agents/therapeutic use , Feces/parasitology , HTLV-I Infections/pathology , Intestinal Obstruction/pathology , Ivermectin/therapeutic use , Strongyloidiasis/diagnosis , Abdominal Pain/parasitology , Aged, 80 and over , Animals , Anorexia , HTLV-I Infections/drug therapy , Humans , Intestinal Obstruction/drug therapy , Intestinal Obstruction/parasitology , Male , Strongyloides stercoralis , Strongyloidiasis/drug therapy , Treatment Outcome , Weight Loss
16.
Pan Afr Med J ; 34: 11, 2019.
Article in English | MEDLINE | ID: mdl-31762880

ABSTRACT

Diagnosis and treatment of liver hydatid cysts may be challenging. Many surgical techniques have been proposed for the treatment of liver hydatid cysts, but the problem of the residual cavity still remains controversial and challenging, especially in giant liver hydatid cysts which are rare entities that have not been widely described in the literature so far. Capitonnage, external tube drainage and omentoplasty are the most commonly used techniques. Herein, we report the case of a 70-year-old man with a mild upper quadrant pain that proved to have a giant liver hydatid cyst, 21*14 cm2, occupying the entire right lobe of the liver. We describe a successful surgical approach with cyst unroofing and careful evacuation of the multiple daughter cysts by aspiration, and the effective management of the residual cavity by the combination of all three aforementioned techniques.


Subject(s)
Abdominal Pain/etiology , Echinococcosis, Hepatic/diagnosis , Abdominal Pain/parasitology , Aged , Drainage , Echinococcosis, Hepatic/surgery , Greece , Hospitals, Public , Humans , Male , Tertiary Care Centers
17.
J Radiol Case Rep ; 13(1): 11-16, 2019 Jan.
Article in English | MEDLINE | ID: mdl-31565163

ABSTRACT

We report a case of a 39 year old male who presented with nausea and right upper quadrant pain. Marked eosinophilia and a hypoechoic liver lesion on ultrasound were identified. The differential diagnosis included neoplasms, infectious diseases and hepatic abscess. Indirect hemagglutination test using purified adult Fasciola hepatica f1Ag confirmed serologic diagnosis of fascioliasis. Radiologists should keep in mind the importance of correlating imaging, clinical and laboratory findings in order to reach the correct diagnosis.


Subject(s)
Fasciola hepatica/isolation & purification , Fascioliasis/diagnosis , Ultrasonography , Abdominal Pain/parasitology , Adult , Animals , Diagnosis, Differential , Fascioliasis/complications , Fascioliasis/diagnostic imaging , Humans , Liver/diagnostic imaging , Liver/parasitology , Male
18.
Korean J Parasitol ; 57(3): 295-298, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31284353

ABSTRACT

Fasciolopsiasis is rarely known as the parasitic disease in Nepal. Herein, we report a case of fasciolopsiasis in a 22-year-old man who was admitted in the hospital with abdominal pain, distension and loss of appetite for a month. He had previously diagnosed with acute viral hepatitis but, his abdominal pain was not resolving despite improvement in his liver function and general condition. During endoscopy an adult digenean worm was seen in the first part of the duodenum. After isolation, the worm was identified morphologically as Fasciolopsis buski. Microscogic examination of the patient's stool revealed eggs with a morphology consistent with F. buski. Eggs were yellow-brown, ellipsoidal, unembmbryonated, operculated, filled with yolk cells, with thin shell and ranging 118-130 µm in length and 60-69 µm in width. The abdominal pain of the patient was resolved after treatment with praziquantel. By the present study, it was confirmed for the first time that fasciolopsiasis is indigenously transmitted in Nepal. Accordingly, the epidemiological studies in humans and reservoir host animals should be performed intensively in near future.


Subject(s)
Fasciolidae/isolation & purification , Trematode Infections/parasitology , Abdominal Pain/diagnosis , Abdominal Pain/drug therapy , Abdominal Pain/parasitology , Animals , Anthelmintics/therapeutic use , Fasciolidae/genetics , Fasciolidae/growth & development , Feces/parasitology , Humans , Male , Nepal , Praziquantel/therapeutic use , Trematode Infections/diagnosis , Trematode Infections/drug therapy , Young Adult
19.
BMJ Case Rep ; 12(5)2019 May 05.
Article in English | MEDLINE | ID: mdl-31061178

ABSTRACT

Sparganosis is a rare zoonotic parasitosis that is sporadically reported worldwide. In Australia, the causative tapeworms are considered endemic in wildlife animals, however, there have been only five reported human infections. We present three additional cases of sparganosis, involving two Australian born gentlemen who have never travelled overseas and a woman who emigrated from Ethiopia. The first man presented with two unusual subcutaneous lumps that migrated along the anterior abdominal wall connected by a tunnel. The second man presented with two separate lumps, one on the thigh and the other on the left upper abdomen over a 4-week interval. The woman presented with 6 weeks of intermittent fevers, night sweats, abdominal pain and passing intestinal worms. This series of patients suggests that sparganosis is under-recognised in Australia and serves as a reminder for clinicians to the varied presentations that can be characteristic of this lesser known zoonosis.


Subject(s)
Abdominal Wall/parasitology , Foodborne Diseases/parasitology , Neglected Diseases/parasitology , Sparganosis/epidemiology , Spirometra/isolation & purification , Thigh/parasitology , Abdominal Pain/parasitology , Abdominal Wall/surgery , Adult , Aged, 80 and over , Animals , Australia/epidemiology , Female , Fever , Humans , Male , Sparganosis/parasitology , Sparganosis/surgery , Spirometra/growth & development , Thigh/surgery , Treatment Outcome
20.
Am J Trop Med Hyg ; 100(6): 1305-1311, 2019 06.
Article in English | MEDLINE | ID: mdl-30963990

ABSTRACT

Strongyloides stercoralis, a worldwide-distributed soil-transmitted helminth, causes chronic infection which may be life threatening. Limitations of diagnostic tests and nonspecificity of symptoms have hampered the estimation of the global morbidity due to strongyloidiasis. This work aimed at assessing S. stercoralis-associated morbidity through a systematic review and meta-analysis of the available literature. MEDLINE, Embase, CENTRAL, LILACS, and trial registries (WHO portal) were searched. The study quality was assessed using the Newcastle-Ottawa scale. Odds ratios (ORs) of the association between symptoms and infection status and frequency of infection-associated symptoms were calculated. Six articles from five countries, including 6,014 individuals, were included in the meta-analysis-three were of low quality, one of high quality, and two of very high quality. Abdominal pain (OR 1.74 [CI 1.07-2.94]), diarrhea (OR 1.66 [CI 1.09-2.55]), and urticaria (OR 1.73 [CI 1.22-2.44]) were associated with infection. In 17 eligible studies, these symptoms were reported by a large proportion of the individuals with strongyloidiasis-abdominal pain by 53.1% individuals, diarrhea by 41.6%, and urticaria by 27.8%. After removing the low-quality studies, urticaria remained the only symptom significantly associated with S. stercoralis infection (OR 1.42 [CI 1.24-1.61]). Limitations of evidence included the low number and quality of studies. Our findings especially highlight the appalling knowledge gap about clinical manifestations of this common yet neglected soil-transmitted helminthiasis. Further studies focusing on morbidity and risk factors for dissemination and mortality due to strongyloidiasis are absolutely needed to quantify the burden of S. stercoralis infection and inform public health policies.


Subject(s)
Abdominal Pain/physiopathology , Diarrhea/physiopathology , Strongyloides stercoralis/pathogenicity , Strongyloidiasis/epidemiology , Strongyloidiasis/physiopathology , Urticaria/physiopathology , Abdominal Pain/parasitology , Africa/epidemiology , Animals , Asia/epidemiology , Australia/epidemiology , Diarrhea/parasitology , Female , Humans , Japan/epidemiology , Male , Odds Ratio , Risk Factors , Soil/parasitology , Strongyloides stercoralis/physiology , Strongyloidiasis/parasitology , Strongyloidiasis/transmission , Urticaria/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...